β-carboline alkaloids and essential tremor: Exploring the environmental determinants of one of the most prevalent neurological diseases

TheScientificWorldJournal

Volumn 10, Issue , 2010, Pages 1783-1794

  Louis, Elan D ^a,b,c   Zheng, Wei ^d  

^a Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^b Purdue University ^*  (United States)

^c NONE   (United States)

^d PURDUE UNIVERSITY   (United States)

Author keywords

Environmental epidemiology; Essential tremor; Etiology; Harmane; Toxin

Indexed keywords

HARMAN; HARMINE; CARBOLINE DERIVATIVE;

CHEMICAL STRUCTURE; DIETARY INTAKE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; ESSENTIAL TREMOR; FAMILIAL DISEASE; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; REVIEW; UNITED STATES; ANIMAL; BLOOD; BRAIN; CHEMISTRY; METABOLISM; RISK ASSESSMENT; RISK FACTOR;

ANIMALS; BRAIN; CARBOLINES; ESSENTIAL TREMOR; HARMINE; HUMANS; MOLECULAR STRUCTURE; RISK ASSESSMENT; RISK FACTORS;

EID: 78349233895     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2010.159     Document Type: Review

References (119)

1. Louis, E.D. (2001) Clinical practice. Essential tremor. N. Engl. J. Med. 345, 887-891.
2. Busenbark, K.L., Nash, J., Nash, S., Hubble, J.P., and Koller, W.C. (1991) Is essential tremor benign? Neurology 41, 1982-1983.
3. Bain, P.G., Findley, L.J., Thompson, P.D., Gresty, M.A., Rothwell, J.C., Harding, A.E., and Marsden, C.D. (1994) A study of hereditary essential tremor. Brain 117(Pt 4), 805-824.
4. Louis, E.D., Barnes, L., Albert, S.M., Cote, L., Schneier, F.R., Pullman, S.L., and Yu, Q. (2001) Correlates of functional disability in essential tremor. Mov. Disord. 16, 914-920.
5. Koller, W., Biary, N., and Cone, S. (1986) Disability in essential tremor: effect of treatment. Neurology 36, 1001-1004.
6. Leegwater-Kim, J., Louis, E.D., Pullman, S.L., Floyd, A.G., Borden, S., Moskowitz, C.B., and Honig, L.S. (2006) Intention tremor of the head in patients with essential tremor. Mov. Disord. 21, 2001-2005. (Pubitemid 44848956)
7. Louis, E.D. (2005) Essential tremor. Lancet Neurol. 4, 100-110.
8. Cohen, O., Pullman, S., Jurewicz, E., Watner, D., and Louis, E.D. (2003) Rest tremor in patients with essential tremor: prevalence, clinical correlates, and electrophysiologic characteristics. Arch. Neurol. 60, 405-410. (Pubitemid 36314367)
9. Singer, C., Sanchez-Ramos, J., and Weiner, W.J. (1994) Gait abnormality in essential tremor. Mov. Disord. 9, 193-196.
10. Stolze, H., Petersen, G., Raethjen, J., Wenzelburger, R., and Deuschl, G. (2001) The gait disorder of advanced essential tremor. Brain 124, 2278-2286.
11. Lombardi, W.J., Woolston, D.J., Roberts, J.W., and Gross, R.E. (2001) Cognitive deficits in patients with essential tremor. Neurology 57, 785-790.
12. Lacritz, L.H., Dewey, R., Jr., Giller, C., and Cullum, C.M. (2002) Cognitive functioning in individuals with "benign" essential tremor. J. Int. Neuropsychol. Soc. 8, 125-129.
13. Duane, D.D. and Vermilion, K.J. (2002) Cognitive deficits in patients with essential tremor. Neurology 58, 1706.
14. Sahin, H.A., Terzi, M., Ucak, S., Yapici, O., Basoglu, T., and Onar, M. (2006) Frontal functions in young patients with essential tremor: a case comparison study. J. Neuropsychiatry Clin. Neurosci. 18, 64-72.
15. Gasparini, M., Bonifati, V., Fabrizio, E., Fabbrini, G., Brusa, L., Lenzi, G.L., and Meco, G. (2001) Frontal lobe dysfunction in essential tremor: a preliminary study. J. Neurol. 248, 399-402.
16. Benito-Leon, J., Louis, E.D., and Bermejo-Pareja, F. (2006) Population-based case-control study of cognitive function in essential tremor. Neurology 66, 69-74.
17. Bermejo-Pareja, F., Louis, E.D., and Benito-Leon, J. (2007) Risk of incident dementia in essential tremor: a population-based study. Mov. Disord. 22, 1573-1580. (Pubitemid 47477918)
18. Thawani, S.P., Schupf, N., and Louis, E.D. (2009) Essential tremor is associated with dementia: prospective population-based study in New York. Neurology 73, 621-625.
19. Benito-Leon, J., Louis, E.D., and Bermejo-Pareja, F. (2009) Risk of incident Parkinson's disease and parkinsonism in essential tremor: a population based study. J. Neurol. Neurosurg. Psychiatry 80, 423-425.
20. Louis, E.D., Benito-Leon, J., Ottman, R., and Bermejo-Pareja, F. (2007) A population-based study of mortality in essential tremor. Neurology 69, 1982-1989. (Pubitemid 350145090)
21. Rajput, A.H., Offord, K.P., Beard, C.M., and Kurland, L.T. (1984) Essential tremor in Rochester, Minnesota: a 45-year study. J. Neurol. Neurosurg. Psychiatry 47, 466-470. (Pubitemid 14145494)
22. Louis, E.D. and Ferreira, J.J. (2010) How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor. Mov. Disord. 25, 534-541.
23. Dogu, O., Sevim, S., Camdeviren, H., Sasmaz, T., Bugdayci, R., Aral, M., Kaleagasi, H., Un, S., and Louis, E.D. (2003) Prevalence of essential tremor: door-to-door neurologic exams in Mersin Province, Turkey. Neurology 61, 1804-1806.
24. Louis, E.D., Faust, P.L., Vonsattel, J.-P.G., Honig, L.S., Rajput, A., Robinson, C.A., Rajput, A., Pahwa, R., Lyons, K.E., Ross, G.W., Borden, S., Moskowitz, C.B., Lawton, A., and Hernandez, N. (2007) Neuropathological changes in essential tremor: 33 cases compared with 21 controls. Brain 130, 3297-3307.
25. Axelrad, J.E., Louis, E.D., Honig, L.S., Flores, I., Ross, G.W., Pahwa, R., Lyons, K.E., Faust, P.L., and Vonsattel, J.P. (2008) Reduced purkinje cell number in essential tremor: a postmortem study. Arch. Neurol. 65, 101-107.
26. Deng, H., Le, W., and Jankovic, J. (2007) Genetics of essential tremor. Brain 130, 1456-1464.
27. Higgins, J.J., Pho, L.T., and Nee, L.E. (1997) A gene (ETM) for essential tremor maps to chromosome 2p22-p25. Mov. Disord. 12, 859-864.
28. Gulcher, J.R., Jonsson, P., Kong, A., Kristjansson, K., Frigge, M.L., Karason, A., Einarsdottir, I.E., Stefansson, H., Einarsdottir, A.S., Sigurthoardottir, S., Baldursson, S., Bjornsdottir, S., Hrafnkelsdottir, S.M., Jakobsson, F., Benedickz, J., and Stefansson, K. (1997) Mapping of a familial essential tremor gene, FET1, to chromosome 3q13. Nat. Genet. 17, 84-87.
29. Shatunov, A., Sambuughin, N., Jankovic, J., Elble, R., Lee, H.S., Singleton, A.B., Dagvadorj, A., Ji, J., Zhang, Y., Kimonis, V.E., Hardy, J., Hallett, M., and Goldfarb, L.G. (2006) Genomewide scans in North American families reveal genetic linkage of essential tremor to a region on chromosome 6p23. Brain 129, 2318-2331. (Pubitemid 44522117)
30. Lambert, D. and Waters, C.H. (1999) Essential tremor. Curr. Treat. Options Neurol. 1, 6-13.
31. Louis, E.D. and Ottman, R. (1996) How familial is familial tremor? The genetic epidemiology of essential tremor. Neurology 46, 1200-1205.
32. Louis, E.D. (2008) Environmental epidemiology of essential tremor. Neuroepidemiology 31, 139-149.
33. Hornabrook, R.W. and Nagurney, J.T. (1976) Essential tremor in Papua, New Guinea. Brain 99, 659-672.
34. Critchley, E. (1972) Clinical manifestations of essential tremor. J. Neurol. Neurosurg. Psychiatry 35, 365-372.
35. Salemi, G., Aridon, P., Calagna, G., Monte, M., and Savettieri, G. (1998) Population-based case-control study of essential tremor. Ital. J. Neurol. Sci. 19, 301-305.
36. Martinelli, P., Gabellini, A.S., Gulli, M.R., and Lugaresi, E. (1987) Different clinical features of essential tremor: a 200-patient study. Acta Neurol. Scand. 75, 106-111.
37. Aiyesimoju, A.B., Osuntokun, B.O., Bademosi, O., and Adeuja, A.O. (1984) Hereditary neurodegenerative disorders in Nigerian Africans. Neurology 34, 361-362. (Pubitemid 14173216)
38. Dogu, O., Louis, E.D., Sevim, S., Kaleagasi, H., and Aral, M. (2005) Clinical characteristics of essential tremor in Mersin, Turkey - a population-based door-to-door study. J. Neurol. 252, 570-574.
39. Tanner, C.M., Goldman, S.M., Lyons, K.E., Aston, D.A., Tetrud, J.W., Welsh, M.D., Langston, J.W., and Koller, W.C. (2001) Essential tremor in twins: an assessment of genetic vs environmental determinants of etiology. Neurology 57, 1389-1391.
40. Lorenz, D., Frederiksen, H., Moises, H., Kopper, F., Deuschl, G., and Christensen, K. (2004) High concordance for essential tremor in monozygotic twins of old age. Neurology 62, 208-211.
41. Louis, E.D. (2001) Etiology of essential tremor: should we be searching for environmental causes? Mov. Disord. 16, 822-829.
42. Larsson, T. and Sjogren, T. (1960) Essential tremor: a clinical and genetic population study. Acta Psychiatr. Scand. Suppl. 36, 1-176.
43. Louis, E.D., Ford, B., Frucht, S., Barnes, L.F., X-Tang, M., and Ottman, R. (2001) Risk of tremor and impairment from tremor in relatives of patients with essential tremor: a community-based family study. Ann. Neurol. 49, 761-769. (Pubitemid 32530243)
44. Gorell, J.M., Johnson, C.C., Rybicki, B.A., Peterson, E.L., Kortsha, G.X., Brown, G.G., and Richardson, R.J. (1999) Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease. Neurotoxicology 20, 239-247.
45. Gorell, J.M., Johnson, C.C., Rybicki, B.A., Peterson, E.L., Kortsha, G.X., Brown, G.G., and Richardson, R.J. (1997) Occupational exposures to metals as risk factors for Parkinson's disease. Neurology 48, 650-658.
46. Gorell, J.M., Johnson, C.C., Rybicki, B.A., Peterson, E.L., and Richardson, R.J. (1998) The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living. Neurology 50, 1346-1350.
47. Rybicki, B.A., Johnson, C.C., Uman, J., and Gorell, J.M. (1993) Parkinson's disease mortality and the industrial use of heavy metals in Michigan. Mov. Disord. 8, 87-92.
48. Racette, B.A., McGee-Minnich, L., Moerlein, S.M., Mink, J.W., Videen, T.O., and Perlmutter, J.S. (2001) Welding-related parkinsonism: clinical features, treatment, and pathophysiology. Neurology 56, 8-13.
49. Baldereschi, M., Inzitari, M., Vanni, P., Di Carlo, A., and Inzitari, D. (2007) Pesticide exposure might be a strong risk factor for Parkinson's disease. Ann. Neurol. 63, 128.
50. Dick, F.D. (2006) Parkinson's disease and pesticide exposures. Br. Med. Bull. 79-80, 219-231.
51. Ritz, B. and Yu, F. (2000) Parkinson's disease mortality and pesticide exposure in California 1984-1994. Int. J. Epidemiol. 29, 323-329.
52. Semchuk, K.M., Love, E.J., and Lee, R.G. (1992) Parkinson's disease and exposure to agricultural work and pesticide chemicals. Neurology 42, 1328-1335.
53. Shcherbatykh, I. and Carpenter, D.O. (2007) The role of metals in the etiology of Alzheimer's disease. J. Alzheimers Dis. 11, 191-205. (Pubitemid 47010984)
54. Perl, D.P. (1985) Relationship of aluminum to Alzheimer's disease. Environ. Health Perspect. 63, 149-153.
55. Morahan, J.M., Yu, B., Trent, R.J., and Pamphlett, R. (2007) Genetic susceptibility to environmental toxicants in ALS. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144, 885-890. (Pubitemid 47547988)
56. McKenna, D.J. (1996) Plant hallucinogens: springboards for psychotherapeutic drug discovery. Behav. Brain Res. 73, 109-116.
57. Zetler, G., Singbartl, G., and Schlosser, L. (1972) Cerebral pharmacokinetics of tremor-producing harmala and iboga alkaloids. Pharmacology 7, 237-248.
58. Sakai, S. (1995) [Chemical studies of indole alkaloids]. Yakugaku Zasshi 115, 351-369.
59. De Meester, C. (1995) Genotoxic potential of beta-carbolines: a review. Mutat. Res. 339, 139-153.
60. Guan, Y., Louis, E.D., and Zheng, W. (2001) Toxicokinetics of tremorogenic natural products, harmane and harmine, in male Sprague-Dawley rats. J. Toxicol. Environ. Health A 64, 645-660.
61. Langston, J.W., Langston, E.B., and Irwin, I. (1984) MPTP-induced parkinsonism in human and non-human primates - clinical and experimental aspects. Acta Neurol. Scand. Suppl. 100, 49-54.
62. Smeyne, R.J. and Jackson-Lewis, V. (2005) The MPTP model of Parkinson's disease. Brain Res. Mol. Brain Res. 134, 57-66.
63. Serra, P.A., Pluchino, S., Marchetti, B., Desole, M.S., and Miele, E. (2008) The MPTP mouse model: cues on DA release and neural stem cell restorative role. Parkinsonism Relat. Disord. 14(Suppl 2), S189-193.
64. Du, W., Aloyo, V.J., and Harvey, J.A. (1997) Harmaline competitively inhibits [3H]MK-801 binding to the NMDA receptor in rabbit brain. Brain Res. 770, 26-29.
65. Martin, F.C. and Handforth, A. (2006) Carbenoxolone and mefloquine suppress tremor in the harmaline mouse model of essential tremor. Mov. Disord. 21, 1641-1649.
66. Martin, F.C., Thu Le, A., and Handforth, A. (2005) Harmaline-induced tremor as a potential preclinical screening method for essential tremor medications. Mov. Disord. 20, 298-305.
67. Krahl, S.E., Martin, F.C., and Handforth, A. (2004) Vagus nerve stimulation inhibits harmaline-induced tremor. Brain Res. 1011, 135-138.
68. Handforth, A. and Krahl, S.E. (2001) Suppression of harmaline-induced tremor in rats by vagus nerve stimulation. Mov. Disord. 16, 84-88. (Pubitemid 36041118)
69. Sinton, C.M., Krosser, B.I., Walton, K.D., and Llinas, R.R. (1989) The effectiveness of different isomers of octanol as blockers of harmaline-induced tremor. Pflugers Arch. 414, 31-36.
70. Milner, T.E., Cadoret, G., Lessard, L., and Smith, A.M. (1995) EMG analysis of harmaline-induced tremor in normal and three strains of mutant mice with Purkinje cell degeneration and the role of the inferior olive. J. Neurophysiol. 73, 2568-2577.
71. Trouvin, J.H., Jacqmin, P., Rouch, C., Lesne, M., and Jacquot, C. (1987) Benzodiazepine receptors are involved in tabernanthine-induced tremor: in vitro and in vivo evidence. Eur. J. Pharmacol. 140, 303-309.
72. Fuentes, J.A. and Longo, V.G. (1971) An investigation on the central effects of harmine, harmaline and related beta-carbolines. Neuropharmacology 10, 15-23.
73. Cross, A.J., Misra, A., Sandilands, A., Taylor, M.J., and Green, A.R. (1993) Effect of chlormethiazole, dizocilpine and pentobarbital on harmaline-induced increase of cerebellar cyclic GMP and tremor. Psychopharmacology (Berl.) 111, 96-98.
74. Rappaport, M.S., Gentry, R.T., Schneider, D.R., and Dole, V.P. (1984) Ethanol effects on harmaline-induced tremor and increase of cerebellar cyclic GMP. Life Sci. 34, 49-56.
75. O'Hearn, E., Long, D.B., and Molliver, M.E. (1993) Ibogaine induces glial activation in parasagittal zones of the cerebellum. Neuroreport 4, 299-302. (Pubitemid 23101468)
76. O'Hearn, E. and Molliver, M.E. (1993) Degeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline. Neuroscience 55, 303-310. (Pubitemid 23211343)
77. O'Hearn, E. and Molliver, M.E. (1997) The olivocerebellar projection mediates ibogaine-induced degeneration of Purkinje cells: a model of indirect, trans-synaptic excitotoxicity. J. Neurosci. 17, 8828-8841. (Pubitemid 27481748)
78. Robertson, H.A. (1980) Harmaline-induced tremor: the benzodiazepine receptor as a site of action. Eur. J. Pharmacol. 67, 129-132.
79. Louis, E.D., Faust, P.L., Vonsattel, J.P., Honig, L.S., Rajput, A., Robinson, C.A., Pahwa, R., Lyons, K.E., Ross, G.W., Borden, S., Moskowitz, C.B., Lawton, A., and Hernandez, N. (2007) Neuropathological changes in essential tremor: 33 cases compared with 21 controls. Brain 130, 3297-3307.
80. Lewin, L. (1928) Untersuchungen Uber Banisteria caapi Sp. Arch. Exp. Pathol. Pharmacol. 129, 133-149.
81. Pennes, H.H. and Hoch, P.H. (1957) Psychotomimetics, clinical and theoretical considerations: harmine, Win-2299 and nalline. Am. J. Psychiatry 113, 887-892.
82. Skog, K., Augustsson, K., Steineck, G., Stenberg, M., and Jagerstad, M. (1997) Polar and non-polar heterocyclic amines in cooked fish and meat products and their corresponding pan residues. Food Chem. Toxicol. 35, 555-565.
83. Skog, K., Solyakov, A., Arvidsson, P., and Jagerstad, M. (1998) Analysis of nonpolar heterocyclic amines in cooked foods and meat extracts using gas chromatography-mass spectrometry. J. Chromatogr. A 803, 227-233.
84. Gearhart, D.A., Collins, M.A., Lee, J.M., and Neafsey, E.J. (2000) Increased beta-carboline 9N-methyltransferase activity in the frontal cortex in Parkinson's disease. Neurobiol. Dis. 7, 201-211.
85. Wakabayashi, K., Totsuka, Y., Fukutome, K., Oguri, A., Ushiyama, H., and Sugimura, T. (1997) Human exposure to mutagenic/carcinogenic heterocyclic amines and comutagenic beta-carbolines. Mutat. Res. 376, 253-259.
86. Pfau, W. and Skog, K. (2004) Exposure to beta-carbolines norharman and harman. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 802, 115-126.
87. Gross, G.A., Turesky, R.J., Fay, L.B., Stillwell, W.G., Skipper, P.L., and Tannenbaum, S.R. (1993) Heterocyclic aromatic amine formation in grilled bacon, beef and fish and in grill scrapings. Carcinogenesis 14, 2313-2318.
88. Skog, K. (1993) Cooking procedures and food mutagens: a literature review. Food Chem. Toxicol. 31, 655-675.
89. Layton, D.W., Bogen, K.T., Knize, M.G., Hatch, F.T., Johnson, V.M., and Felton, J.S. (1995) Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis 16, 39-52.
90. Louis, E.D., Zheng, W., Jiang, W., Bogen, K.T., and Keating, G.A. (2007) Quantification of the neurotoxic beta-carboline harmane in barbecued/grilled meat samples and correlation with level of doneness. J. Toxicol. Environ. Health A 70, 1014-1019. (Pubitemid 46752502)
91. Herraiz, T. (2004) Relative exposure to beta-carbolines norharman and harman from foods and tobacco smoke. Food Addit. Contam. 21, 1041-1050.
92. Zheng, W., Wang, S., Barnes, L.F., Guan, Y., and Louis, E.D. (2000) Determination of harmane and harmine in human blood using reversed-phased high-performance liquid chromatography and fluorescence detection. Anal. Biochem. 279, 125-129. (Pubitemid 30164999)
93. Louis, E.D., Zheng, W., Jurewicz, E.C., Watner, D., Chen, J., Factor-Litvak, P., and Parides, M. (2002) Elevation of blood beta-carboline alkaloids in essential tremor. Neurology 59, 1940-1944.
94. Louis, E.D., Jiang, W., Pellegrino, K.M., Rios, E., Factor-Litvak, P., Henchcliffe, C., and Zheng, W. (2008) Elevated blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor. Neurotoxicology 29, 294-300.
95. Louis, E.D., Shungu, D.C., Chan, S., Mao, X., Jurewicz, E.C., and Watner, D. (2002) Metabolic abnormality in the cerebellum in patients with essential tremor: a proton magnetic resonance spectroscopic imaging study. Neurosci. Lett. 333, 17-20.
96. Pagan, F.L., Butman, J.A., Dambrosia, J.M., and Hallett, M. (2003) Evaluation of essential tremor with multi-voxel magnetic resonance spectroscopy. Neurology 60, 1344-1347.
97. Tedeschi, G., Bertolino, A., Campbell, G., Barnett, A.S., Duyn, J.H., Jacob, P.K., Moonen, C.T., Alger, J.R., and Di Chiro, G. (1996) Reproducibility of proton MR spectroscopic imaging findings. AJNR Am. J. Neuroradiol. 17, 1871-1879.
98. Vion-Dury, J., Nicoli, F., Salvan, A.M., Confort-Gouny, S., Dhiver, C., and Cozzone, P.J. (1995) Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy. Lancet 345, 60-61.
99. Louis, E.D. and Vonsattel, J.P. (2007) The emerging neuropathology of essential tremor. Mov. Disord. 23, 174-182.
100. Louis, E.D., Zheng, W., Mao, X., and Shungu, D.C. (2007) Blood harmane is correlated with cerebellar metabolism in essential tremor: a pilot study. Neurology 69, 515-520. (Pubitemid 47357258)
101. Louis, E.D., Rios, E., Pellegrino, K.M., Jiang, W., Factor-Litvak, P., and Zheng, W. (2008) Higher blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations correlate with lower olfactory scores in essential tremor. Neurotoxicology 29, 294-300.
102. Connelly, T., Farmer, J.M., Lynch, D.R., and Doty, R.L. (2003) Olfactory dysfunction in degenerative ataxias. J. Neurol. Neurosurg. Psychiatry 74, 1435-1437.
103. Velazquez-Perez, L., Fernandez-Ruiz, J., Diaz, R., Gonzalez, R.P., Ochoa, N.C., Cruz, G.S., Mederos, L.E., Gongora, E.M., Hudson, R., and Drucker-Colin, R. (2006) Spinocerebellar ataxia type 2 olfactory impairment shows a pattern similar to other major neurodegenerative diseases. J. Neurol. 253, 1165-1169. (Pubitemid 44511473)
104. Sobel, N., Prabhakaran, V., Hartley, C.A., Desmond, J.E., Zhao, Z., Glover, G.H., Gabrieli, J.D., and Sullivan, E.V. (1998) Odorant-induced and sniff-induced activation in the cerebellum of the human. J. Neurosci. 18, 8990-9001.
105. Deiss, V. and Baudoin, C. (1997) Hyposmia for butanol and vanillin in mutant staggerer male mice. Physiol. Behav. 61, 209-213.
106. Applegate, L.M. and Louis, E.D. (2005) Essential tremor: mild olfactory dysfunction in a cerebellar disorder. Parkinsonism Relat. Disord. 11, 399-402.
107. Louis, E.D., Pellegrino, K.M., Factor-Litvak, P., Rios, E., Jiang, W., Henchcliffe, C., and Zheng, W. (2008) Cancer and blood concentrations of the comutagen harmane in essential tremor. Mov. Disord. 23, 1747-1751.
108. Bogen, K.T., Keating, G.A., 2nd, Chan, J.M., Paine, L.J., Simms, E.L., Nelson, D.O., and Holly, E.A. (2007) Highly elevated PSA and dietary PhIP intake in a prospective clinic-based study among African Americans. Prostate Cancer Prostatic Dis. 10, 261-269.
109. Armbrecht, H.J., Lakshmi, V.M., Wickstra, J., Hsu, F.F., and Zenser, T.V. (2007) Metabolism of a heterocyclic amine colon carcinogen in young and old rats. Drug Metab. Dispos. 35, 633-639.
110. Totsuka, Y., Ushiyama, H., Ishihara, J., Sinha, R., Goto, S., Sugimura, T., and Wakabayashi, K. (1999) Quantification of the co-mutagenic beta-carbolines, norharman and harman, in cigarette smoke condensates and cooked foods. Cancer Lett. 143, 139-143. (Pubitemid 29392946)
111. Boisset, M., Billaud, C., and Desjeux, J.F. (1994) Studies on the mechanism of intestinal passage of the food comutagen harman, in the rabbit. Food Chem. Toxicol. 32, 349-356.
112. Louis, E.D., Zheng, W., Applegate, L., Shi, L., and Factor-Litvak, P. (2005) Blood harmane concentrations and dietary protein consumption in essential tremor. Neurology 65, 391-396.
113. Willett, W.C., Sampson, L., Stampfer, M.J., Rosner, B., Bain, C., Witschi, J., Hennekens, C.H., and Speizer, F.E. (1985) Reproducibility and validity of a semiquantitative food frequency questionnaire. Am. J. Epidemiol. 122, 51-65.
114. Louis, E.D., Keating, G.A., Bogen, K.T., Rios, E., Pellegrino, K.M., and Factor-Litvak, P. (2008) Dietary epidemiology of essential tremor: meat consumption and meat cooking practices. Neuroepidemiology 30, 161-166.
115. Das, S.K., Biswas, A., Roy, J., Bose, P., Roy, T., Banerjee, T.K., Mukherjee, C., Raut, D.K., Chowdhury, A., and Hazra, A. (2008) Prevalence of major neurological disorders among geriatric population in the metropolitan city of Kolkata. J. Assoc. Physicians India 56, 175-181.
116. Kuhn, W., Muller, T., Grosse, H., and Rommelspacher, H. (1995) Plasma harman and norharman in Parkinson's disease. J. Neural Transm. Suppl. 46, 291-295.
117. Polanski, W., Enzensperger, C., Reichmann, H., and Gille, G. (2010) The exceptional properties of 9-methyl-beta-carboline: stimulation, protection and regeneration of dopaminergic neurons coupled with anti-inflammatory effects. J. Neurochem. 113, 1659-1675.
118. Louis, E.D., Erickson-Davis, C., Pahwa, R., Lyons, K.E., Garber, A., Moskowitz, C.B., Lawton, A., Faust, P.L., and Vonsattel, J.P. (2010) Essential tremor with ubiquitinated Purkinje cell intranuclear inclusions. Acta Neuropathol. 119, 375-377.
119. Shill, H.A., Adler, C.H., Sabbagh, M.N., Connor, D.J., Caviness, J.N., Hentz, J.G., and Beach, T.G. (2008) Pathologic findings in prospectively ascertained essential tremor subjects. Neurology 70, 1452-1455.